Accelerating drug development for neuroblastoma - New Drug Development Strategy: an Innovative Therapies for Children with Cancer, European Network for Cancer Research in Children and Adolescents and International Society of Paediatric Oncology Euro
about
Early and late effects of pharmacological ALK inhibition on the neuroblastoma transcriptome.Autophagy inhibition improves the cytotoxic effects of receptor tyrosine kinase inhibitors.Updated clinical and biological information from the two-stage phase II study of imatinib mesylate in subjects with relapsed/refractory neuroblastoma
P2860
Accelerating drug development for neuroblastoma - New Drug Development Strategy: an Innovative Therapies for Children with Cancer, European Network for Cancer Research in Children and Adolescents and International Society of Paediatric Oncology Euro
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
Accelerating drug development ...... ty of Paediatric Oncology Euro
@en
type
label
Accelerating drug development ...... ty of Paediatric Oncology Euro
@en
prefLabel
Accelerating drug development ...... ty of Paediatric Oncology Euro
@en
P2093
P2860
P50
P1476
Accelerating drug development ...... ty of Paediatric Oncology Euro
@en
P2093
Alexander Schramm
Andrew Dj Pearson
Angelika Eggert
Birgit Geoerger
Deborah A Tweddle
Elizabeth R Tucker
Frank Berthold
Gilles Vassal
Giuseppe Barone
Gudrun Schleiermacher
P2860
P304
P356
10.1080/17460441.2017.1340269
P407
P577
2017-06-12T00:00:00Z